Defense Verdict Returned By Ohio Federal Jury In Depakote Birth Defect Trial
(February 3, 2017, 9:58 AM EST) -- CLEVELAND — An Ohio federal jury on Feb. 2 returned a defense verdict for Abbott Laboratories Inc. and spinoff AbbVie Inc. in a Depakote birth defect trial (Z.H., et al. v....
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login